A controlled clinical study on efficacy and safety of periocular triamcinolone acetonide injection for treating ocular myasthenia gravis
Abstract Objective To evaluate the efficacy and safety of peribulbar triamcinolone acetonide injection for treating ocular myasthenia gravis (OMG), with a comparison of traditional oral drug therapy. Methods A total of 22 patients with OMG who received periocular triamcinolone acetonide injection (i...
Main Authors: | Minghua Shi, Zhuneng Lu, Aijiao Qin, Jing Cheng, Simin Chen, Yiqiao Xing |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-01-01
|
Series: | BMC Ophthalmology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12886-024-03313-z |
Similar Items
-
Ocular myasthenia gravis and thymoma
by: Victor Alegre-Ituarte, et al.
Published: (2022-09-01) -
Peribulbar injection of triamcinolone acetonide as an outpatient clinic procedure in the management of mild to moderate macular edema
by: Mohammed S Ahmed
Published: (2021-01-01) -
Tolosa-Hunt syndrome with general myasthenia gravis involvement
by: Lu Li, Zhe Wang, Ming-Ou Lu
Published: (2020-06-01) -
Clinical Features and Prognosis of Ocular Myasthenia Gravis Patients with Different Phenotypes
by: Li-Li Wang, et al.
Published: (2015-01-01) -
Mitochondrial bioenergetics in ocular fibroblasts of two myasthenia gravis cases
by: Tarin A. Europa, et al.
Published: (2022-06-01)